[CAPR] Capricor Therapeutics, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 2.53 Change: 0.13 (5.42%)
Ext. hours: Change: 0 (0%)

chart CAPR

Refresh chart

Strongest Trends Summary For CAPR

CAPR is in the medium-term up 261% in 1 year. In the long-term down -98% in 18 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS-0.86 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 71.59% Sales Growth - Q/Q27.53% P/E-0.81
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-30.88% ROE-115.81% ROI-50.49%
Current Ratio3.37 Quick Ratio Long Term Debt/Equity0.51 Debt Ratio1.03
Gross Margin Operating Margin-149.05% Net Profit Margin-153.3% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities16.48 M Cash From Investing Activities-15.52 M Cash From Operating Activities-2.05 M Gross Profit
Net Profit-3.48 M Operating Profit-3.41 M Total Assets27.47 M Total Current Assets25.42 M
Total Current Liabilities7.55 M Total Debt9.16 M Total Liabilities20.15 M Total Revenue1.79 M
Technical Data
High 52 week6.23 Low 52 week0.32 Last close2.95 Last change-9.23%
RSI14.04 Average true range0.4 Beta0.31 Volume60.2 K
Simple moving average 20 days-36.18% Simple moving average 50 days-23.35% Simple moving average 200 days85.98%
Performance Data
Performance Week-22.77% Performance Month-12.46% Performance Quart404.27% Performance Half478.43%
Performance Year112.23% Performance Year-to-date619.51% Volatility daily15.66% Volatility weekly35.01%
Volatility monthly71.75% Volatility yearly248.54% Relative Volume125.77% Average Volume791.49 K
New High New Low

News

2019-10-14 09:35:01 | CHF Solutions System to be Used in JAHVH Study After Final Nod

2019-10-07 12:27:47 | A Look At Benzinga Pro's Most-Searched Tickers For October 7, 2019

2019-10-07 06:30:00 | Capricor Presents Additional Positive Data from Ongoing HOPE-2 Study of CAP-1002 in Duchenne Muscular Dystrophy at World Muscle Society: Data Demonstrates Improved PUL 2.0 Performance at 6 Months

2019-10-04 10:09:02 | Zynex ZYXI Scales 52-Week High: What's Driving the Stock?

2019-10-02 09:15:00 | Capricor to Present Interim Results from the HOPE-2 Trial in a Late Breaking Session of the World Muscle Society and Company to Host Conference Call Monday, October 7 at 5:30 AM PT / 8:30 AM ET

2019-10-01 09:14:01 | Abbott ABT Gets FDA Nod for Spinal Cord Stimulation System

2019-09-26 11:24:03 | Align Gains on Innovation Despite Poor Case Shipment in China

2019-09-26 09:47:01 | Natera NTRA Scales 52-Week High: What's Driving the Stock?

2019-09-25 08:44:12 | Illumina ILMN Inks Deal to Develop Distributable Test Kits

2019-09-24 11:25:03 | FDA Nods to Medtronic's MDT New Age Evolut PRO+ TAVR

2019-09-24 09:20:01 | Insulet Receives FDA Approval for ACE Pump Implementation

2019-09-24 07:42:00 | Capricor Therapeutics shares climb 3.6% on news FDA to meet to discuss DMD treatment

2019-09-24 07:30:00 | Capricor Therapeutics to Meet with FDA to Discuss CAP-1002 to Treat Duchenne Muscular Dystrophy

2019-09-23 09:44:01 | Bruker BRKR Enters Into Alliance With Murdoch University

2019-09-21 08:20:21 | Did You Manage To Avoid Capricor Therapeutics's NASDAQ:CAPR Devastating 92% Share Price Drop?

2019-09-20 09:12:01 | Neogen Forms Partnership With IGS to Enhance Beef Profile

2019-09-19 08:41:12 | Medtronic Receives European Nod for Glucose Monitoring System

2019-09-17 12:29:15 | A Look At Benzinga Pro's Most-Searched Tickers For September 17, 2019

2019-09-17 08:38:12 | Abbott Partners With Sanofi to Upgrade Diabetes Management

2019-09-17 07:00:00 | Capricor Therapeutics to Present Results from the HOPE-2 Trial of CAP-1002 in Duchenne Muscular Dystrophy in a Late Breaking Session of the World Muscle Society

2019-09-11 09:04:01 | Baxter's BAX Cheetah Acquisition to Aid Patient Monitoring

2019-09-06 07:30:00 | Capricor Therapeutics to Present at Upcoming Conferences

2019-08-23 08:37:12 | Neogen Gets AOAC Validation for NeoSeek to Ensure Food Safety

2019-08-22 07:31:11 | NuVasive's New TLIF Implant Broadens Spine Surgery Option

2019-08-20 09:03:01 | Boston Scientific's BSX Vercise Gevia DBS Gets FDA Nod

2019-08-16 10:24:10 | Here's What We Think About Capricor Therapeutics, Inc.'s NASDAQ:CAPR CEO Pay

2019-08-06 18:05:10 | Capricor Therapeutics CAPR Reports Q2 Loss, Tops Revenue Estimates

2019-08-06 16:00:00 | Capricor Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

2019-08-01 10:32:02 | Will Capricor Therapeutics CAPR Report Negative Q2 Earnings? What You Should Know

2019-07-30 08:00:00 | Capricor Therapeutics to Present Second Quarter 2019 Financial Results and Recent Corporate Update on August 6

2019-07-25 07:00:00 | Capricor Therapeutics Announces Positive DSMB Safety and Futility Review and Continuation of its HOPE-2 Study in Duchenne Muscular Dystrophy

2019-07-17 07:00:00 | Capricor Therapeutics and Parents Project Muscular Dystrophy to Host Webinar to Discuss Interim Analysis of the HOPE-2 Clinical Trial to Treat Patients with Duchenne Muscular Dystrophy

2019-07-16 12:44:57 | A Look At Benzinga Pro's Most-Searched Tickers For July 16, 2019

2019-07-15 14:59:14 | Capricor Therapeutics News: Why CAPR Stock Is Skyrocketing Today

2019-07-15 08:45:00 | Capicor Therapeutics' stock rockets on heavy volume after positive MD trial results

2019-07-15 06:00:00 | Capricor Therapeutics Announces Positive Results from its Interim Analysis in the HOPE-2 Trial to Treat Patients with Duchenne Muscular Dystrophy

2019-07-02 14:23:10 | What Kind Of Shareholders Own Capricor Therapeutics, Inc. NASDAQ:CAPR?

2019-05-13 17:15:09 | Capricor Therapeutics CAPR Reports Q1 Loss, Lags Revenue Estimates

2019-05-13 16:06:12 | Capricor: 1Q Earnings Snapshot

2019-05-13 16:00:00 | Capricor Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update

2019-05-13 14:30:00 | Capricor Therapeutics, Inc. to Host Earnings Call

2019-05-06 16:00:00 | Capricor Therapeutics to Present First Quarter 2019 Financial Results and Recent Corporate Update on May 13

2019-04-05 10:52:26 | Will Capricor Therapeutics, Inc.'s NASDAQ:CAPR Earnings Grow In The Years Ahead?

2019-03-28 16:25:39 | Capricor: 4Q Earnings Snapshot

2019-03-28 16:00:00 | Capricor Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

2019-03-21 08:00:00 | Capricor Therapeutics to Present Fourth Quarter and Full Year 2018 Financial Results and Recent Corporate Update on March 28

2019-02-21 07:40:02 | Capricor Therapeutics, Inc. NASDAQ:CAPR: Commentary On Fundamentals

2019-02-06 07:00:00 | Capricor Resumes Dosing of Enrolled Patients in HOPE-2 Clinical Trial for Duchenne Muscular Dystrophy

2019-01-24 09:30:00 | 4 Healthcare Stocks Looking To Have A Strong Thursday 1/24/19

2019-01-24 07:00:00 | Neurology Publishes Study Reporting Significant Improvements in Duchenne Muscular Dystrophy Patients Treated with Capricor’s Novel Cell Therapy